Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion—A subanalysis of the EXPLORE trial. Issue 6 (15th April 2020)

• Record Type: Journal Article
• Authors: Kolk, Maarten Z. H.; van Veelen, Anna; Agostoni, Pierfrancesco; van Houwelingen, Gert K.; Ouweneel, Dagmar M.; Hoebers, Loes P.; Råmunddal, Truls; Laanmets, Peep; Eriksen, Erlend; Bax, Matthijs; Suttorp, Maarten J.; Claessen, Bimmer E. P. M.; van der Schaaf, René J.; Elias, Joëlle; van Dongen, Ivo M.; Henriques, José P. S.
• Is Part Of: Catheterization and cardiovascular interventions. Volume 97:Issue 6(2021)
• Page Start: 1176
• Page End: 1183
• Publication Date: 2020-04-15
• Subjects: CMR -- CTO -- ECG -- PCI -- STEMI; Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.28904
• Languages: English
• ISSNs: 1522-1946

Abstract

Abstract: Objective: To evaluate predictors of procedural success of percutaneous coronary intervention (PCI) of chronic total coronary occlusions (CTOs) in a non‐infarct‐related artery following ST‐segment elevation myocardial infarction (STEMI), and demonstrate the effect on left ventricular functionality (LVF), infarct size (IS), and pro‐arrhythmic electrocardiogram (ECG) parameters. Background: Predictors of unsuccessful revascularization of a CTO are numerous, although following STEMI, these are lacking. Besides, effects of failed CTO PCI (FPCI) on the myocardium are unknown. Methods: This is a subanalysis of the EXPLORE trial, in which 302 STEMI patients with a concurrent CTO were randomized to CTO PCI ( n = 147) or no‐CTO PCI (NPCI, n = 154). For the purpose of this subanalysis, we divided patients into successful CTO PCI (SPCI, n = 106), FPCI ( n = 41), and NPCI ( n = 154) groups. Cardiac magnetic resonance imaging and angiographic data were derived from the EXPLORE database, combined with ECG parameters. To gain more insight, all outcomes were compared with patients that did not undergo CTO PCI. Results: In multivariate regression, only CTO lesion length >20 mm was an independent predictor of procedural failure (OR 3.31 [1.49–7.39]). No significant differences in median left ventricular ejection fraction, left ventricular end‐diastolic volume, IS, and the pro‐arrhythmic ECG parameters such as QT‐dispersion, QTc‐time, and TpTe‐intervals were seen between the SPCI and FPCI groups at 4 months follow‐up. Conclusion: This subanalysis of the EXPLORE trial has demonstrated that a CTO lesion length >20 mm is an independent predictor of CTO PCI failure, whereas procedural failure did not lead to any adverse effects on LVF nor pro‐arrhythmic ECG parameters.